Kyntra Bio, Inc. (KYNB)
8.00
+0.02
(+0.31%)
USD |
NASDAQ |
Sep 11, 16:00
8.00
0.00 (0.00%)
After-Hours: 16:43
Kyntra Bio Gross Profit (TTM) : 0.076M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.076M |
| March 31, 2026 | 2.60M |
| December 31, 2025 | 5.135M |
| September 30, 2025 | 12.77M |
| June 30, 2025 | 11.29M |
| March 31, 2025 | 10.32M |
| December 31, 2024 | 12.19M |
| September 30, 2024 | 5.046M |
| June 30, 2024 | 41.48M |
| March 31, 2024 | 80.01M |
| December 31, 2023 | 108.66M |
| September 30, 2023 | 136.61M |
| June 30, 2023 | 112.15M |
| March 31, 2023 | 96.54M |
| December 31, 2022 | 120.46M |
| September 30, 2022 | 101.85M |
| June 30, 2022 | 240.54M |
| March 31, 2022 | 234.53M |
| December 31, 2021 | 207.63M |
| September 30, 2021 | 253.69M |
| June 30, 2021 | 139.83M |
| March 31, 2021 | 157.13M |
| December 31, 2020 | 145.41M |
| September 30, 2020 | 90.56M |
| June 30, 2020 | 81.47M |
| Date | Value |
|---|---|
| March 31, 2020 | 47.18M |
| December 31, 2019 | 29.21M |
| September 30, 2019 | 27.16M |
| June 30, 2019 | 27.42M |
| March 31, 2019 | 69.80M |
| December 31, 2018 | 69.80M |
| September 30, 2018 | 69.80M |
| June 30, 2018 | 81.43M |
| March 31, 2018 | 67.76M |
| December 31, 2017 | 93.13M |
| September 30, 2017 | 93.13M |
| June 30, 2017 | 54.09M |
| March 31, 2017 | 25.37M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Vericel Corp. | 228.38M |
| Capricor Therapeutics, Inc. | -2.095M |
| ARS Pharmaceuticals, Inc. | 83.45M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |